"We screened the Investors Business Daily (IBD) and Zacks databases to find companies whose earnings are accelerating and whose earnings estimates are being increased by analysts," says J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter continues, "All of the stocks in our list have IBD Composite Ratings of 95 (99 is best) and Zacks Ratings of 1 or 2 (1 is best). These recommendations offer excellent appreciation potential with moderate risk.

Friday's fourth-quarter GDP numbers offered more evidence that the economy is picking up steam, but one of the biggest obstacles to the recovery remains the stubbornly high unemployment rate. We'll find out whether there's been any movement on that front when employment data for January comes out this week. The Challenger Job-Cut report and ADP employment data are due Wednesday, and the government's unemployment rate on Friday. Another mild increase in jobs is expected, in line with the three-month average, but not enough to significantly reduce the unemployment rate.

Also look for the ISM manufacturing and nonmanufacturing indexes this week, as well as the Chicago PMI and the New York NAPM index. And Fed Chairman Ben Bernanke will speak to the National Press Club on Thursday.

Analyst Upgrades

• General Electric (GE) and Barclays (BCS) to buy from neutral at UBS.
• Warnaco (WRC) to outperform from market perform and Melco Crown (MPEL) to market perform from underperform at Wells Fargo.
• Parker-Hannifin (PH) and Emerson Electric (EMR) to buy from neutral at Goldman.
• AMD (AMD) to buy from neutral at Nomura.
• Novellus (NVLS) and Sherwin-Williams (SHW) to equal weight from underweight at Morgan Stanley.
• OpenTable (OPEN) to outperform from market perform at Morgan Keegan.
• Skilled Healthcare (SKH) to buy from hold at Jefferies.
• Lear (LEA) to overweight from equal weight at Barclays.
• Adobe (ADBE) to buy from neutral at BofA/Merrill.

The earnings crunch continues this week, and analysts surveyed by Thomson Reuters are anticipating lots of strong quarterly reports.

For example, year-over-year earnings growth from big oil Chevron (CVX), ConocoPhillips (COP), ExxonMobil (XOM) and Royal Dutch Shell (RDS.A) are expected to be in double digits. The same is true of many other energy and mining concerns reporting this week: Allegheny Technologies (ATI), Alliant Energy (LNT), Arch Coal (ACI), Cliffs Natural Resources (CLF), CMS Energy (CMS), CONSOL Energy (CNX), DPL (DPL), Hess Corp. (HES), Minerals Technologies (MTX), Pioneer Natural Resources (PXD), PPL Corp. (PPL), Southwestern Energy (SWN), Total (TOT), Whiting Petroleum (WLL), Williams Companies (WMB) and Wisconsin Energy (WEC).

After a horrible 2009, this year is shaping up much better for the semiconductor operators. Just look at Novellus (NVLS). In its latest quarterly report, the company beat expectations as the stock price is up over 3% to $27.47. Actually, the stock has roughly doubled over the past year. And in light of the rebound in the market, the momentum is likely to continue.

Analyst Upgrades

• Citigroup upgraded JPMorgan (JPM) to buy from hold on valuation as it finds the risk/reward on shares attractive following yesterday's sell-off. Citi keeps a $48 price target on the stock.
• Oppenheimer upgraded International Game Tech (IGT) to outperform from perform as it believes fundamentals for slot suppliers will improve over the next two years. The firm has a $29 price target on the stock.
• SunTrust believes Perry Ellis (PERY) is now positioned to deliver stronger margins and significant reductions in charge-backs. Shares were upgraded to buy from neutral.
• Nordstrom (JWN) was upgraded to neutral from underperform at BofA/Merrill.
• Tyson Foods (TSN) was upgraded to buy from hold at BB&T.
• Consol Energy (CNX) was upgraded to buy from neutral at Goldman.

TheStreet.com's Jim Cramer says you take your life into your own hands if you fade the opening in today's market.

A year ago with the futures up, all you could think of is how much you wanted to "fade" that opening, how great it would be just to lay out any shorts into strength. You could choose pretty much anything going into earnings season.

The techs? Last good quarter. The banks? A travesty. You didn't even know if the banks you are short would survive. The oils? Free fall. The metals? Amazing downward pressure coming from hedge fund redemptions. The insurers? Will they make it? Retail? The balance sheets looked terrible going into what would be a terrible holiday selling season. The autos and auto-related? Disaster.

Analyst upgrades:

• Roth Capital upgraded MicroStrategy (NASDAQ: MSTR) to Buy from Hold and raised its target to $90 from $70, citing encouraging Q2 results, new product cycle catalysts, a lift from Europe, and cost reductions.
• William Blair upgraded Costco (NASDAQ: COST) to Outperform from Market Perform after meeting with management as it believes sales and earnings could beat expectations over the next year.
• Credit Suisse upgraded Novellus (NASDAQ: NVLS) to Outperform from Neutral and raised its target to $29 from $23. The firm cites higher Samsung capex forecast, high leverage, and low expectations.
• Home Properties (NYSE: HME) and Equity Residential (NYSE: EQR) were upgraded to Outperform from Market Perform at FBC Capital, while Douglas Emmett (NYSE: DEI) and Duke Realty (NYSE: DRE) were raised to Market Perform from Underperform.
• Agilent (NYSE: A) was upgraded to Overweight from Equal Weight at Barclays.
• Cytec Industries (NYSE: CYT) was upgraded to Buy from Hold at KeyBanc.

TheStreet.com's Jim Cramer says the diamonds in the rough don't get much press, but they're the real heroes in this market.

The troubled airline industry. The troubled auto industry. Have they ever not been "troubled"? For as long as I have been in this business, these two industries have been in huge trouble. Yet somehow it is news that United (NASDAQ: UAUA) (Cramer's Take), AMR (NYSE: AMR) (Cramer's Take) and Delta (NYSE: DAL) (Cramer's Take) are in trouble. Somehow we're still sweating the auto program -- and I, for one, thought Steve Rattner was doing a pretty good job and don't want to read into his resignation because too many times in my life I have seen the smear and know it for what it is.

I want to talk about the industries that aren't troubled. Last night CSX (NYSE: CSX) (Cramer's Take) reported a hugely profitable quarter despite a big decline in revenues. At one point the rail industry was a hugely troubled industry and you used to worry about the companies swinging to big losses every downturn. Now CSX gets 6 inches of ink today and the deeply troubled airline industry gets reams.

After the closing bell sounded yesterday, Novellus Systems (NASDAQ: NVLS) reported a second-quarter loss, thanks to falling semiconductor sales stemming from general weakness in the semiconductor sector.

The firm reported a second-quarter net loss of 52 cents per share, or 41 cents per share excluding items. Although this loss was three cents wider than the consensus estimate, the shares managed to bounce off their after-hours lows -- thanks mainly to NVLS's forecast.

TheStreet.com's Jim Cramer says an earnings surprise from Philips, like Alcoa last week, didn't do much to put markets in gear.

Upside surprise No. 2, Philips (NYSE: PHG) (Cramer's Take), doesn't seem to do anything more than upside surprise No. 1, Alcoa (NYSE: AA) (Cramer's Take). That's right, we got a quick run-up for Philips when it reported a nice profit, but no follow-through from the rest of the markets in Europe after this electronics company reported.

Why should there be, though? Philips might as well have said "this profit is a sham" from the commentary it put out --more firings, numbers down huge from last year, terrible outlook.

Analyst upgrades:

• JPMorgan upgraded Franklin Resources (NYSE: BEN) to Overweight from Underweight to reflect performance and sales improvements, as well as benefits from the weakening U.S. dollar. The firm has a $94 target on the stock.
• Oppenheimer upgraded FormFactor (NASDAQ: FORM) to Outperform from Perform after channel checks indicated orders are recovering. The firm raised its target on shares to $30 from $22.
• KeyBanc upgraded Oshkosh (NYSE: OSK) to Buy from Hold citing the company's MRAP-ATV contract win, which they view as a "game changer." The firm has a $30 target on the stock.
• Novellus (NASDAQ: NVLS) was upgraded to Neutral from Underperform at Credit Suisse.
• Ternium (NYSE: TX) was upgraded to Buy from Neutral at Goldman.
• Cathay General (NASDAQ: CATY) was upgraded to Buy from Neutral at B. Riley.

Analyst upgrades:

• Oppenheimer upgraded FTI Consulting (NYSE:FCN) to Outperform from Perform on expectations the stock will outperform in the second half of 2009 due to easier comparisons and a "deeper and longer" restructuring cycle. The firm has a $62 target on shares.
• Citigroup upgraded Cigna (NYSE:CI) to Hold from Sell to reflect reduced balance sheet risk following the company's capital raise and the potential for a PBM sale. The firm raised its target price to $23 from $13.
• Goldman expects Coca-Cola Enterprises (NYSE:CCE) to benefit from favorable soda demand and lower commodity costs. The firm upgraded shares to Conviction Buy from Buy and has a $20 target on the stock.
• Novellus (NASDAQ:NVLS) was raised to Buy from Neutral at Bank of America/Merrill.
• CME Group (NASDAQ:CME) was upgraded at JP Morgan to Neutral from Underweight.
• Allegiant (NASDAQ:ALGT) was upgraded to Overweight from Equal Weight at Morgan Stanley.
  

Analyst upgrades:

• JP Morgan upgraded J.C. Penney (NYSE: JCP) to Neutral from Underweight based on lower input costs, stabilization in home, lower markdown dollars, and valuation.
• Oppenheimer upgraded Novellus (NASDAQ: NVLS) to Perform from Underperform as it believes Novellus' market share has stabilized and that the company is a potential acquisition target. The firm raised its price target to $20 from $9.
• Bernstein upgraded ConAgra (NYSE: CAG) to Market Perform from Underperform citing strength in grains and moderating input costs.
• ConocoPhillips (NYSE: COP) was raised to Buy from Neutral at Goldman.
• China Housing (NASDAQ: CHLN) was upgraded to Buy from Hold at Roth Capital.

Analyst upgrades:

• Citigroup upgraded shares of Akamai (NASDAQ: AKAM) to Buy from Hold following the company's Q4 results as they believe fundamentals are stabilizing. The firm raised their target price to $22 from $12.
  
• Baird upgraded Theravance (NASDAQ: THRX) to Outperform from Neutral. The firm said the company looks poised to realize the two-product success necessary to drive profitability, and Horizon will likely play a role in succeeding $7B+ Advair. Note that last night Theravance/Glaxo (GSK) reported positive results for Horizon.
  
• RBC Capital said Aeterna Zentaris (NASDAQ: AEZS) is on the cusp of a Cetrorelix deal and has turned more positive on shares. Shares were upgraded to Outperform from Sector Perform.
  
• Marvell Tech (NASDAQ: MRVL) was upgraded to Buy from Neutral at Goldman and added to the firm's Conviction Buy List.
  
• Sangamo BioSciences (NASDAQ: SGMO) was raised to Buy from Neutral at Merriman.
  
• Arthur J. Gallagher (NYSE: AJG) was upgraded at Piper Jaffray to Buy from Neutral.